AMA: Trump administration requiring pricing information in TV drug ads

| 2 Min Read

Statement attributable to:

Barbara L. McAneny, MD 

President, American Medical Association

“The Trump Administration has taken a step in the right direction by requiring pricing information in direct-to-consumer television advertising of prescription drugs. Last year, the AMA called for regulations requiring the ads to include the manufacturer’s list price of those drugs, and we have supported similar legislative efforts. This small dose of transparency will help patients have a more complete picture when faced with prescription drug ads. 

 

Full press statement available when you sign in

Sign in to the AMA website to get the full version of this press statement. 

AMA membership has its advantages

  • Be a part of the nation's largest physician organization
  • Play a role in shaping the future of health care
  • Enjoy exclusive perks and savings

Not a member? Become a member now.

 

FEATURED STORIES

Doctor with text bubbles and graphic elements

Deepfake “doctors” are a problem—here are 7 keys to stopping them

| 4 Min Read
Light bulb with

How to bring physician well-being initiatives to life

| 14 Min Read
Healthcare worker in empty hospital operating room

These physician specialties score highest on resident well-being

| 11 Min Read
Train passenger distressed by motion sickness

What doctors want patients to know about motion sickness

| 10 Min Read